The University of Southampton
University of Southampton Institutional Repository

Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G?³A ALS mice: overlapping effects or limited therapeutic opportunity?

Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G?³A ALS mice: overlapping effects or limited therapeutic opportunity?
Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G?³A ALS mice: overlapping effects or limited therapeutic opportunity?
Background: amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disease characterized by the loss of motoneurons (MNs) in the spinal cord, brainstem and motor cortex, causing progressive paralysis and death. Nowadays, there is no effective therapy and most patients die 2-5 years after diagnosis. Sigma-1R is a transmembrane protein highly expressed in the CNS and specially enriched in MNs. Mutations on the Sigma-1R leading to frontotemporal lobar degeneration-ALS were recently described in human patients. We previously reported the therapeutic role of the selective sigma-1R agonist 2-(4-morpholi-nethyl)1-phenylcyclohexanecarboxylate (PRE-084) in SOD1G93A ALS mice, that promoted spinal MN preservation and extended animal survival by controlling NMDA receptor calcium influx. Resveratrol (RSV, trans-3,4',5-trihydroxystilbene) is a natural polyphenol with promising neuroprotective effects. We recently found that RSV administration to SOD1G93A mice preserves spinal MN function and increases mice survival. These beneficial effects were associated to activation of Sirtuin 1 (Sirt1) and AMP-activated protein kinase (AMPK) pathways, leading to the modulation of autophagy and an increase of mitochondrial biogenesis. The main goal of this work was to assess the effect of combined RSV and PRE-084 administration in SOD1G93A ALS mice.

Methods: we determined the locomotor performance of the animals by rotarod test and evaluated spinal motoneuron function using electrophysiological tests.

Results: RSV plus PRE-084 treatment from 8 weeks of age significantly improved locomotor performance and spinal MN function, accompanied by a significant reduction of MN degeneration and an extension of mice lifespan. In agreement with our previous findings, there was an induction of PKC-specific phosphorylation of the NMDA-NR1 subunit and an increased expression and activation of Sirt1 and AMPK in the ventral spinal cord of treated SOD1G93A animals.

Conclusions: although combined PRE and RSV treatment significantly ameliorated SOD1G93A mice, it did not show a synergistic effect compared to RSV-only and PRE-084-only treated groups.
1750-1172
78-89
Mancuso, Renzo
05786562-a993-4e37-926e-3c1fcf50b36d
Del Valle, Jaume
691e0d19-509e-4967-a250-761f6e75f41e
Morell, Marta
e16cb77d-53d8-419c-9dd8-d084ce1a1a4e
Pallás, Mercé
59c1a88c-003f-4efa-8389-0b71a0726ece
Osta, Rosario
64007891-e6c1-4242-ab1c-0c5e69276431
Navarro, Xavier
8854ebaa-d283-4d46-829e-c7c8f186585e
Mancuso, Renzo
05786562-a993-4e37-926e-3c1fcf50b36d
Del Valle, Jaume
691e0d19-509e-4967-a250-761f6e75f41e
Morell, Marta
e16cb77d-53d8-419c-9dd8-d084ce1a1a4e
Pallás, Mercé
59c1a88c-003f-4efa-8389-0b71a0726ece
Osta, Rosario
64007891-e6c1-4242-ab1c-0c5e69276431
Navarro, Xavier
8854ebaa-d283-4d46-829e-c7c8f186585e

Mancuso, Renzo, Del Valle, Jaume, Morell, Marta, Pallás, Mercé, Osta, Rosario and Navarro, Xavier (2014) Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G?³A ALS mice: overlapping effects or limited therapeutic opportunity? Orphanet Journal of Rare Diseases, 9, 78-89. (doi:10.1186/1750-1172-9-78). (PMID:21896316)

Record type: Article

Abstract

Background: amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disease characterized by the loss of motoneurons (MNs) in the spinal cord, brainstem and motor cortex, causing progressive paralysis and death. Nowadays, there is no effective therapy and most patients die 2-5 years after diagnosis. Sigma-1R is a transmembrane protein highly expressed in the CNS and specially enriched in MNs. Mutations on the Sigma-1R leading to frontotemporal lobar degeneration-ALS were recently described in human patients. We previously reported the therapeutic role of the selective sigma-1R agonist 2-(4-morpholi-nethyl)1-phenylcyclohexanecarboxylate (PRE-084) in SOD1G93A ALS mice, that promoted spinal MN preservation and extended animal survival by controlling NMDA receptor calcium influx. Resveratrol (RSV, trans-3,4',5-trihydroxystilbene) is a natural polyphenol with promising neuroprotective effects. We recently found that RSV administration to SOD1G93A mice preserves spinal MN function and increases mice survival. These beneficial effects were associated to activation of Sirtuin 1 (Sirt1) and AMP-activated protein kinase (AMPK) pathways, leading to the modulation of autophagy and an increase of mitochondrial biogenesis. The main goal of this work was to assess the effect of combined RSV and PRE-084 administration in SOD1G93A ALS mice.

Methods: we determined the locomotor performance of the animals by rotarod test and evaluated spinal motoneuron function using electrophysiological tests.

Results: RSV plus PRE-084 treatment from 8 weeks of age significantly improved locomotor performance and spinal MN function, accompanied by a significant reduction of MN degeneration and an extension of mice lifespan. In agreement with our previous findings, there was an induction of PKC-specific phosphorylation of the NMDA-NR1 subunit and an increased expression and activation of Sirt1 and AMPK in the ventral spinal cord of treated SOD1G93A animals.

Conclusions: although combined PRE and RSV treatment significantly ameliorated SOD1G93A mice, it did not show a synergistic effect compared to RSV-only and PRE-084-only treated groups.

Other
ptpmcrender.fcgi_accid=PMC4035830&blobtype=pdf - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 19 May 2014
Published date: 21 May 2014
Organisations: Centre for Biological Sciences

Identifiers

Local EPrints ID: 376143
URI: http://eprints.soton.ac.uk/id/eprint/376143
ISSN: 1750-1172
PURE UUID: b9f85d75-40de-483d-9b55-7efc4f5ac26a

Catalogue record

Date deposited: 27 Apr 2015 10:24
Last modified: 11 Nov 2019 20:45

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×